Ashfield appoints new Director

Richard Clarke will be the new Commercial and Patient Solutions Business Development Director

Richard Clarke, new Commercial and Patient Solutions Business Development Director

Ashfield has announced the appointment of Richard Clarke as Commercial and Patient Solutions Business Development Director.

Richard has over 30 years' experience in the pharmaceutical industry and has previously held National and Global roles within GSK and AstraZeneca including Head of Global SFE and UK Head of Commercial Learning and Development.

The insights that Richard has gained throughout his career will provide Ashfield with valuable thought leadership and a real edge in developing superior commercial solutions for its clients.

Mick O'Leary, Regional President for Ashfield Commercial and Patient Solutions said: "I strongly believe that Richard will fit in well with our organisation and will share the same values and high standards in exceeding our clients" expectations. His industry expertise will be invaluable as he guides the future direction for the transforming UK business".

Richard Clarke, said: "I am delighted to be joining at this exciting time for the UK business, and to be part of the Ashfield team". Richard will be part of the UK Management Team and will have responsibility for Ashfield's Commercial and Patient Solutions business development activities in the UK from 1 October 2019.

Ashfield's Commercial team provides contract sales services to pharma companies while the Patient Solutions department designs and delivers nurse-led patient support services.

Ashfield, part of UDG Healthcare, is a global company in commercialisation services for the healthcare industry.